| Primary |
| Drug Use For Unknown Indication |
66.7% |
| Vascular Dementia |
33.3% |
|
| Ischaemic Cardiomyopathy |
100.0% |
|
| Secondary |
| Product Used For Unknown Indication |
38.0% |
| Drug Abuse |
28.5% |
| Drug Use For Unknown Indication |
14.4% |
| Tourette's Disorder |
5.1% |
| Intentional Overdose |
2.6% |
| Suicide Attempt |
2.5% |
| Abnormal Behaviour |
2.0% |
| Pyrexia |
1.4% |
| Tic |
0.9% |
| Insomnia |
0.7% |
| Epilepsy |
0.6% |
| Anxiety |
0.5% |
| Attention Deficit/hyperactivity Disorder |
0.5% |
| Depression |
0.5% |
| Behavioural And Psychiatric Symptoms Of Dementia |
0.4% |
| Hypothyroidism |
0.4% |
| Infection |
0.4% |
| Dyslipidaemia |
0.2% |
| Gastrointestinal Disorder |
0.2% |
| Hypertension |
0.2% |
|
| Suicide Attempt |
14.0% |
| Syncope |
10.0% |
| Respiratory Distress |
8.0% |
| White Blood Cell Count Increased |
8.0% |
| Delirium |
6.0% |
| Thrombocytopenia |
6.0% |
| Tic |
6.0% |
| Death |
4.0% |
| Hyponatraemia |
4.0% |
| Keratoconus |
4.0% |
| Parkinsonism |
4.0% |
| Somnolence |
4.0% |
| Surgery |
4.0% |
| Therapy Cessation |
4.0% |
| Tooth Discolouration |
4.0% |
| Bicytopenia |
2.0% |
| Blood Creatine Phosphokinase Increased |
2.0% |
| Body Temperature Increased |
2.0% |
| Cataract |
2.0% |
| Drug Ineffective For Unapproved Indication |
2.0% |
|
| Concomitant |
| Drug Use For Unknown Indication |
42.2% |
| Parkinson's Disease |
14.1% |
| Product Used For Unknown Indication |
9.6% |
| Dementia |
5.2% |
| Attention Deficit/hyperactivity Disorder |
4.1% |
| Cardiac Disorder |
3.0% |
| Hypertension |
3.0% |
| Epilepsy |
2.6% |
| Acute Myocardial Infarction |
1.9% |
| Atrial Fibrillation |
1.9% |
| Tourette's Disorder |
1.9% |
| Diabetes Mellitus Non-insulin-dependent |
1.5% |
| Migraine |
1.5% |
| Abnormal Behaviour |
1.1% |
| Affective Disorder |
1.1% |
| Bipolar I Disorder |
1.1% |
| Depression |
1.1% |
| Pain |
1.1% |
| Pneumonia Bacterial |
1.1% |
| Prophylaxis |
1.1% |
|
| Hepatitis Cholestatic |
12.2% |
| Drug Level Decreased |
9.8% |
| Renal Impairment |
9.8% |
| Drug Ineffective |
4.9% |
| Dystonia |
4.9% |
| Off Label Use |
4.9% |
| Somnolence |
4.9% |
| Subdural Haematoma |
4.9% |
| Tendonitis |
4.9% |
| Tension |
4.9% |
| Therapy Regimen Changed |
4.9% |
| Toxicity To Various Agents |
4.9% |
| Weight Increased |
4.9% |
| White Blood Cell Count Increased |
4.9% |
| Agitation |
2.4% |
| Anaemia |
2.4% |
| Blood Bilirubin Increased |
2.4% |
| Bradycardia |
2.4% |
| Delirium |
2.4% |
| Electrocardiogram Qt Prolonged |
2.4% |
|
| Interacting |
| Drug Use For Unknown Indication |
91.7% |
| Epilepsy |
8.3% |
|
| Drug Level Decreased |
100.0% |
|
